A vaccine against erysipelothrix rhusiopathiae and porcine parvo virus
AssigneeIntervet Inc.
InventorAntonius Arnoldus Christiaan JACOBS
Life of this patent
Estimating the term…
Abstract
The invention pertains to the use of a vaccine comprising a non-replicating immunogen of Erysipelothrix rhusiopathiae and a non-replicating immunogen of porcine parvo virus, in prophylactically treating a pig against an infection with Erysipelothrix rhusiopathiae and an infection with porcine parvo virus, by injection of the first vaccine into the dermis of the pig.
Claims20
A method for prophylactically treating a pig against an infection with Erysipelothrix rhusiopathiae and an infection with porcine parvo virus, comprising injecting a first vaccine comprising a non-replicating immunogen of Erysipelothrix rhusiopathiae and a non-replicating immunogen of porcine parvo virus into the dermis of the pig.
A method of preventing the infection of a pig with Erysipelothrix rhusiopathiae and an infection with porcine parvo virus, comprising administering by injection to the dermis of the pig, wherein the first vaccine comprises a non-replicating immunogen of Erysipelothrix rhusiopathiae and a non-replicating immunogen of porcine parvo virus.
Dependencies are inferred from the claim text.